EVGN
EVOGENE LTD.Recent alerts on EVGN
All signals →
SEC filing
EVGN Reports $4.6M Revenue, $0.06 EPS, Expands Pharma Collaborations, Advances ChemPass AI, Discontinues Lavie Bio Operations
13d ago
SEC filing
EVGN Reports $13.8M 2025 OpEx, $3.2M Q4 OpEx, ChemPass AI 90% Precision, Lavie Bio Sold to ICL, Focus on Pharma/Ag
89d ago
Scanner
Unusual volume (2.0x average)
125d ago
Get push alerts for EVGN
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS